Case study:
Building a Scalable Quality Management System and SOP Suite for an Emerging Biotech Company
Background:
A rapidly growing biotechnology company was transitioning from an early-stage research environment to a more structured development organisation. As the business prepared for increased regulatory scrutiny, technology transfer activities, and future clinical and commercial ambitions, leadership recognised that its existing quality documentation and processes were no longer sufficient to support growth.
The organisation needed a fit-for-purpose Quality Management System (QMS) and a comprehensive suite of Standard Operating Procedures (SOPs) that would establish control, improve consistency, and create a framework for sustainable compliance.
Boyds was engaged to provide quality and compliance expertise, helping the client design and implement a practical, scalable quality infrastructure aligned with industry expectations.
The Challenge
Like many emerging biotech companies, the client’s quality processes had evolved organically. While individual teams were operating effectively, documentation standards and governance processes varied across functions.
Key challenges included:
- Limited formal quality documentation.
- Inconsistent document control practices.
- Lack of a structured deviation, CAPA, and change control process.
- Unclear roles and responsibilities for quality oversight.
- Need for procedures aligned with GxP and industry best practices.
- Limited internal resources available to develop and maintain a quality system.
The company required a QMS that would meet immediate operational needs while supporting future regulatory inspections, partner audits, and organisational growth.
Boyds approach
Boyds adopted a collaborative approach, working closely with stakeholders across Quality, Operations, Development, Manufacturing, and Leadership teams.
- Quality System Assessment
The engagement began with a detailed review of existing processes, documentation, and organisational requirements.
Through stakeholder interviews and gap assessments, Boyds identified:
- Existing strengths and effective practices.
- Areas of compliance risk.
- Missing quality system elements.
- Process improvement opportunities.
This assessment formed the foundation of the client’s quality roadmap.
- QMS Framework Development
Boyds designed a structured QMS framework tailored to the company’s stage of development and future objectives.
The framework established clear governance for:
- Document control
- Training management
- Deviations and non-conformances
- Corrective and Preventive Actions (CAPA)
- Change control
- Risk management
- Supplier quality management
- Internal audits
- Management review activities
The system was intentionally designed to be scalable, allowing additional quality processes to be integrated as the organisation matured.
- SOP Development Programme
Working together with subject matter experts, Boyds developed a comprehensive suite of SOPs covering critical quality and operational processes.
Boyds:
- Drafted SOPs using industry-standard templates.
- Defined clear process flows and responsibilities.
- Incorporated regulatory and quality best practices.
- Facilitated stakeholder review workshops.
- Managed document revisions and approvals.
The result was a harmonised and user-friendly SOP library that supported both compliance and operational effectiveness.
- Implementation and Staff Engagement
Recognising that successful quality systems depend on user adoption, Boyds supported implementation activities through:
- SOP walkthrough sessions.
- Training materials and guidance documents.
- Process owner coaching.
- Quality governance recommendations.
This hands-on approach helped ensure employees understood not only the procedures themselves but also the rationale behind them.
Impact and Outcomes
Following implementation, the biotech company achieved a significant increase in quality system maturity.
Key outcomes included:
A Complete Foundational QMS
A structured Quality Management System was implemented, providing clear governance and consistent quality oversight across the organisation.
Comprehensive SOP Library
The client gained a suite of robust SOPs covering critical quality and operational activities, creating consistency across departments and improving process ownership.
Improved Inspection and Audit Readiness
With defined processes, documented controls, and clear responsibilities, the organisation was better prepared for partner audits, regulatory interactions, and future growth milestones.
Enhanced Quality Culture
Employee engagement and training activities helped embed quality awareness throughout the business, fostering a culture of accountability and continuous improvement.
Scalable Platform for Growth
The new QMS provided a solid foundation capable of supporting future expansion, technology transfers, clinical development programmes, and commercial activities.
Client Benefits
By partnering with Boyds, the client was able to:
- Accelerate quality system development without diverting internal resources.
- Implement industry-aligned quality processes efficiently.
- Reduce compliance risks.
- Establish clear operational controls.
- Build confidence with investors, partners, and stakeholders.
- Create a scalable framework to support long-term business growth.
Conclusion
For emerging biotechnology companies, establishing a robust Quality Management System is critical to supporting growth, maintaining compliance, and ensuring operational excellence. Through a collaborative and pragmatic approach, Boyds helped this client transform a collection of informal processes into a structured, sustainable quality framework, delivering a comprehensive SOP suite and a scalable QMS that positioned the organisation for future success.